DULOSE lactulose 667 mg/mL oral liquid bottle
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
26-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
lactulose, Quantity: 667 mg/mL
Available from:
Viatris Pty Ltd
INN (International Name):
Lactulose
Pharmaceutical form:
Oral Liquid
Composition:
Excipient Ingredients:
Administration route:
Oral
Units in package:
500 mL
Prescription type:
Not scheduled. Not considered by committee
Therapeutic indications:
Treatment of acute, and prevention and treatment of chronic portal-systemic encephalopathy (PSE), including the stages of hepatic pre-coma and coma.,Treatment of chronic and habitual constipation.,Where a soft stool is considered of medical benefit (haemorrhoids, post-colonic/anal surgery).
Product summary:
Visual Identification: Clear, colourless to brownish-yellow, viscous liquid.; Container Type: Bottle; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Authorization status:
Registered
Authorization date:
2014-02-13
